{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Screening",
        "instanceType": "AnalysisPopulation",
        "description": "The Screened Set will include all participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form (ICF)"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Enrollment",
        "instanceType": "AnalysisPopulation",
        "description": "The Enrolled Set will include all participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "The Full Analysis (FA) Set will include all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "The Per Protocol (PP) Set will include all participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint.",
        "criteria": "In FA Set with no major protocol deviations impacting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "The Safety Set will include all participants who received at least 1 dose of study drug. The Safety Set will be the primary population for all safety analyses.",
        "criteria": "Received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "The Pharmacokinetic (PK) Analysis Set will include all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter.",
        "criteria": "In Safety Set with sufficient plasma concentration data for at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "The Pharmacodynamic (PD) Analysis Set will include all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter.",
        "criteria": "In Safety Set with sufficient PD data for at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age of the participant at baseline."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant."
      },
      {
        "id": "char_5",
        "name": "Wilson Disease history",
        "dataType": "Mixed",
        "instanceType": "Characteristic",
        "description": "Wilson Disease history, including time since diagnosis and initial presentation."
      },
      {
        "id": "char_6",
        "name": "Baseline laboratory values",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory values including ceruloplasmin, serum copper, and 24-hour urinary copper excretion."
      },
      {
        "id": "char_7",
        "name": "Baseline clinical assessments",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline clinical assessments, including the Unified Wilsonâ€™s Disease Rating Scale (UWDRS)."
      },
      {
        "id": "char_8",
        "name": "Medical/Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical and surgical history of the participant."
      },
      {
        "id": "char_9",
        "name": "Prior medications for Wilson Disease",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease."
      },
      {
        "id": "char_10",
        "name": "Body Mass Index (BMI)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body mass index calculated as weight (kg)/[height (m)]^2."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 10
    }
  }
}